Successful renal transplantation in presensitized recipients with double-filtration plasmapheresis and 15-deoxyspergualin.
Miura
S
S
Department of Surgery, Sendai Shakaihoken Hospital, Japan.
Okazaki
H
H
Sato
T
T
Amada
N
N
Sakurada
M
M
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D003131:Combined Modality Therapy; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors
D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D003404:Creatinine; D001379:Azathioprine; C037258:gusperimus